Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001104659-15-050232)

Filing Details

Accession Number:: 0001104659-15-050232
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2015-07-08 08:00:55
Reporting Period:: 2015-07-07

Filing Date:: 2015-07-08
Accepted Time:: 2015-07-08 08:00:55
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1359931	Proteon Therapeutics Inc	PRTO	Biological Products, (No Disgnostic Substances) (2836)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1619811	Philip Daniel Gottlieb	C/O Proteon Therapeutics 200 West Street Waltham MA 02451	Vp Marketing & Bus Development	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2015-06-30	1,965	$8.84	1,965	No	5	A	Direct
Common Stock	Disposition	2015-07-07	1,965	$16.86	0	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	5	A	Direct
No	4	S	Direct

Footnotes

The shares were acquired under the Issuer's 2014 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c).
These shares, acquired under the Issuer's 2014 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c), were sold under Rule 144 and pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 5, 2015.